Annual report
6029.TEDINET S100QHUH
Period2022-01-01 → 2022-12-31
Filed2023-03-30
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 141
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥4.7bn | 2022-01-01 → 2022-12-31 | Cons. | Net sales |
| Revenue | ¥3.2bn | 2021-01-01 → 2021-12-31 | Cons. | Net sales |
| Revenue | ¥2.4bn | 2020-01-01 → 2020-12-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥2.8bn | 2019-01-01 → 2019-12-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥3.5bn | 2018-01-01 → 2018-12-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥3m | 2022-01-01 → 2022-12-31 | Cons. | Operating income |
| Operating income | −¥223m | 2021-01-01 → 2021-12-31 | Cons. | Operating income |
| Ordinary income | ¥15m | 2022-01-01 → 2022-12-31 | Cons. | Ordinary income |
| Ordinary income | −¥225m | 2021-01-01 → 2021-12-31 | Cons. | Ordinary income |
| Ordinary income | −¥396m | 2020-01-01 → 2020-12-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥31m | 2019-01-01 → 2019-12-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥164m | 2018-01-01 → 2018-12-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥27m | 2022-01-01 → 2022-12-31 | Cons. | Income before income taxes |
| Profit before tax | −¥331m | 2021-01-01 → 2021-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥2m | 2022-01-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥351m | 2021-01-01 → 2021-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥441m | 2020-01-01 → 2020-12-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥147m | 2019-01-01 → 2019-12-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥270m | 2018-01-01 → 2018-12-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥2m | 2022-01-01 → 2022-12-31 | Cons. | Profit loss |
| Net income | −¥351m | 2021-01-01 → 2021-12-31 | Cons. | Profit loss |
| Total assets | ¥4.7bn | at 2022-12-31 | Cons. | Assets |
| Total assets | ¥5.6bn | at 2021-12-31 | Cons. | Assets |
| Total assets | ¥4.3bn | at 2020-12-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥4.3bn | at 2019-12-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥4.5bn | at 2018-12-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥3.3bn | at 2022-12-31 | Cons. | Liabilities |
| Total liabilities | ¥4.2bn | at 2021-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥1.3bn | at 2022-12-31 | Cons. | Net assets |
| Net assets / equity | ¥1.4bn | at 2021-12-31 | Cons. | Net assets |
| Net assets / equity | ¥1.4bn | at 2020-12-31d | Cons. | Net assets |
| Net assets / equity | ¥1.8bn | at 2019-12-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥2.0bn | at 2018-12-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.2bn | at 2022-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.8bn | at 2021-12-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.2bn | at 2022-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.8bn | at 2021-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.7bn | at 2020-12-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.4bn | at 2019-12-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥1.5bn | at 2018-12-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | −¥133m | 2022-01-01 → 2022-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥209m | 2021-01-01 → 2021-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥272m | 2020-01-01 → 2020-12-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥148m | 2019-01-01 → 2019-12-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥143m | 2018-01-01 → 2018-12-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥154m | 2022-01-01 → 2022-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥564m | 2021-01-01 → 2021-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥188m | 2020-01-01 → 2020-12-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥292m | 2019-01-01 → 2019-12-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥150m | 2018-01-01 → 2018-12-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥315m | 2022-01-01 → 2022-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥896m | 2021-01-01 → 2021-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥266m | 2020-01-01 → 2020-12-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥313m | 2019-01-01 → 2019-12-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥415m | 2018-01-01 → 2018-12-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥0.22 | 2022-01-01 → 2022-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-36.76 | 2021-01-01 → 2021-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-49.87 | 2020-01-01 → 2020-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-16.71 | 2019-01-01 → 2019-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥30.88 | 2018-01-01 → 2018-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥30.39 | 2018-01-01 → 2018-12-31d | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥133.37 | at 2022-12-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥147.69 | at 2021-12-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥154 | at 2020-12-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥208.95 | at 2019-12-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥228.22 | at 2018-12-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 28.1% | at 2022-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 25.7% | at 2021-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 31.5% | at 2020-12-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 42.5% | at 2019-12-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 44.5% | at 2018-12-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 0.2% | 2022-01-01 → 2022-12-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 14.4% | 2018-01-01 → 2018-12-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 158 | at 2022-12-31 | Cons. | Number of employees |
| Employees | 165 | at 2021-12-31 | Cons. | Number of employees |
| Employees | 112 | at 2020-12-31d | Cons. | Number of employees |
| Employees | 109 | at 2019-12-31d | Cons. | Number of employees |
| Employees | 103 | at 2018-12-31d | Cons. | Number of employees |
| Revenue | ¥1.9bn | 2022-01-01 → 2022-12-31 | Standalone | Net sales |
| Revenue | ¥2.1bn | 2021-01-01 → 2021-12-31 | Standalone | Net sales |
| Revenue | ¥1.9bn | 2020-01-01 → 2020-12-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥2.4bn | 2019-01-01 → 2019-12-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥3.3bn | 2018-01-01 → 2018-12-31d | Standalone | Net sales (5-year summary) |
| Operating income | −¥87m | 2022-01-01 → 2022-12-31 | Standalone | Operating income |
| Operating income | −¥184m | 2021-01-01 → 2021-12-31 | Standalone | Operating income |
| Ordinary income | −¥31m | 2022-01-01 → 2022-12-31 | Standalone | Ordinary income |
| Ordinary income | −¥165m | 2021-01-01 → 2021-12-31 | Standalone | Ordinary income |
| Ordinary income | −¥397m | 2020-01-01 → 2020-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥27m | 2019-01-01 → 2019-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥248m | 2018-01-01 → 2018-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | −¥152m | 2022-01-01 → 2022-12-31 | Standalone | Income before income taxes |
| Profit before tax | −¥295m | 2021-01-01 → 2021-12-31 | Standalone | Income before income taxes |
| Net income | −¥157m | 2022-01-01 → 2022-12-31 | Standalone | Profit loss |
| Net income | −¥298m | 2021-01-01 → 2021-12-31 | Standalone | Profit loss |
| Net income | −¥579m | 2020-01-01 → 2020-12-31d | Standalone | Net income loss (5-year summary) |
| Net income | −¥119m | 2019-01-01 → 2019-12-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥392m | 2018-01-01 → 2018-12-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥3.4bn | at 2022-12-31 | Standalone | Assets |
| Total assets | ¥4.3bn | at 2021-12-31 | Standalone | Assets |
| Total assets | ¥4.2bn | at 2020-12-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥4.3bn | at 2019-12-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥4.4bn | at 2018-12-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥2.3bn | at 2022-12-31 | Standalone | Liabilities |
| Total liabilities | ¥3.1bn | at 2021-12-31 | Standalone | Liabilities |
| Net assets / equity | ¥1.1bn | at 2022-12-31 | Standalone | Net assets |
| Net assets / equity | ¥1.2bn | at 2021-12-31 | Standalone | Net assets |
| Net assets / equity | ¥1.3bn | at 2020-12-31d | Standalone | Net assets |
| Net assets / equity | ¥1.9bn | at 2019-12-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥2.0bn | at 2018-12-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥791m | at 2022-12-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥1.3bn | at 2021-12-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥-16.03 | 2022-01-01 → 2022-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-31.24 | 2021-01-01 → 2021-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-65.52 | 2020-01-01 → 2020-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-13.53 | 2019-01-01 → 2019-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥44.83 | 2018-01-01 → 2018-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥44.11 | 2018-01-01 → 2018-12-31d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥3.5 | 2020-01-01 → 2020-12-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥3.5 | 2019-01-01 → 2019-12-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥3.5 | 2018-01-01 → 2018-12-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥112.21 | at 2022-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥127.34 | at 2021-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥142.64 | at 2020-12-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥213.2 | at 2019-12-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥229.3 | at 2018-12-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 32.1% | at 2022-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 28.7% | at 2021-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 30.4% | at 2020-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 43.8% | at 2019-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 45.4% | at 2018-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 20.8% | 2018-01-01 → 2018-12-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 9,807,000 | at 2022-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 9,767,000 | at 2021-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 8,889,100 | at 2020-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 8,790,100 | at 2019-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 8,759,000 | at 2018-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 83 | at 2022-12-31 | Standalone | Number of employees |
| Employees | 89 | at 2021-12-31 | Standalone | Number of employees |
| Employees | 88 | at 2020-12-31d | Standalone | Number of employees |
| Employees | 88 | at 2019-12-31d | Standalone | Number of employees |
| Employees | 88 | at 2018-12-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 43
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2022-01-01 → 2022-12-31 | −¥7m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-01-01 → 2022-12-31 | −¥7m |
| Reconciling Itemsreconciling | segment assets | at 2022-12-31 | ¥1.1bn |
| Reconciling Itemsreconciling | segment profit | 2022-01-01 → 2022-12-31 | ¥2m |
| Acupuncture Moxibustion And Judo Therapy Clinic Support Businessreportable segment | capex | 2022-01-01 → 2022-12-31 | ¥143m |
| Acupuncture Moxibustion And Judo Therapy Clinic Support Businessreportable segment | depreciation | 2022-01-01 → 2022-12-31 | ¥135m |
| Acupuncture Moxibustion And Judo Therapy Clinic Support Businessreportable segment | employees | at 2022-12-31 | 139 pure |
| Acupuncture Moxibustion And Judo Therapy Clinic Support Businessreportable segment | revenue | 2022-01-01 → 2022-12-31 | ¥2.8bn |
| Acupuncture Moxibustion And Judo Therapy Clinic Support Businessreportable segment | revenue external | 2022-01-01 → 2022-12-31 | ¥2.8bn |
| Acupuncture Moxibustion And Judo Therapy Clinic Support Businessreportable segment | revenue intersegment | 2022-01-01 → 2022-12-31 | ¥7m |
| Acupuncture Moxibustion And Judo Therapy Clinic Support Businessreportable segment | segment assets | at 2022-12-31 | ¥2.3bn |
| Acupuncture Moxibustion And Judo Therapy Clinic Support Businessreportable segment | segment profit | 2022-01-01 → 2022-12-31 | −¥79m |
| Toy Sales Businessreportable segment | capex | 2022-01-01 → 2022-12-31 | ¥14m |
| Toy Sales Businessreportable segment | depreciation | 2022-01-01 → 2022-12-31 | ¥610,000 |
| Toy Sales Businessreportable segment | employees | at 2022-12-31 | 19 pure |
| Toy Sales Businessreportable segment | revenue | 2022-01-01 → 2022-12-31 | ¥1.9bn |
| Toy Sales Businessreportable segment | revenue external | 2022-01-01 → 2022-12-31 | ¥1.9bn |
| Toy Sales Businessreportable segment | segment assets | at 2022-12-31 | ¥1.3bn |
| Toy Sales Businessreportable segment | segment profit | 2022-01-01 → 2022-12-31 | ¥80m |
| —segment total | capex | 2022-01-01 → 2022-12-31 | ¥156m |
| —segment total | depreciation | 2022-01-01 → 2022-12-31 | ¥136m |
| —segment total | revenue | 2022-01-01 → 2022-12-31 | ¥4.7bn |
| —segment total | revenue external | 2022-01-01 → 2022-12-31 | ¥4.7bn |
| —segment total | revenue intersegment | 2022-01-01 → 2022-12-31 | ¥7m |
| —segment total | segment assets | at 2022-12-31 | ¥3.6bn |
| —segment total | segment profit | 2022-01-01 → 2022-12-31 | ¥771,000 |
| Reconciling Itemsreconciling | segment assets | at 2021-12-31 | ¥1.5bn |
| Acupuncture Moxibustion And Judo Therapy Clinic Support Businessreportable segment | capex | 2021-01-01 → 2021-12-31 | ¥56m |
| Acupuncture Moxibustion And Judo Therapy Clinic Support Businessreportable segment | depreciation | 2021-01-01 → 2021-12-31 | ¥131m |
| Acupuncture Moxibustion And Judo Therapy Clinic Support Businessreportable segment | revenue | 2021-01-01 → 2021-12-31 | ¥2.8bn |
| Acupuncture Moxibustion And Judo Therapy Clinic Support Businessreportable segment | revenue external | 2021-01-01 → 2021-12-31 | ¥2.8bn |
| Acupuncture Moxibustion And Judo Therapy Clinic Support Businessreportable segment | segment assets | at 2021-12-31 | ¥2.9bn |
| Acupuncture Moxibustion And Judo Therapy Clinic Support Businessreportable segment | segment profit | 2021-01-01 → 2021-12-31 | −¥256m |
| Toy Sales Businessreportable segment | revenue | 2021-01-01 → 2021-12-31 | ¥325m |
| Toy Sales Businessreportable segment | revenue external | 2021-01-01 → 2021-12-31 | ¥325m |
| Toy Sales Businessreportable segment | segment assets | at 2021-12-31 | ¥1.1bn |
| Toy Sales Businessreportable segment | segment profit | 2021-01-01 → 2021-12-31 | ¥33m |
| —segment total | capex | 2021-01-01 → 2021-12-31 | ¥56m |
| —segment total | depreciation | 2021-01-01 → 2021-12-31 | ¥131m |
| —segment total | revenue | 2021-01-01 → 2021-12-31 | ¥3.2bn |
| —segment total | revenue external | 2021-01-01 → 2021-12-31 | ¥3.2bn |
| —segment total | segment assets | at 2021-12-31 | ¥4.1bn |
| —segment total | segment profit | 2021-01-01 → 2021-12-31 | −¥223m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,412
| Item | Context | Value | Unit |
|---|---|---|---|
| Percentage of shareholdings financial service providers | CurrentYearInstant_OrdinaryShareMember | 0.0649 | |
| Percentage of shareholdings other corporations | CurrentYearInstant_OrdinaryShareMember | 0.3620 | |
| Percentage of shareholdings foreigners other than individuals | CurrentYearInstant_OrdinaryShareMember | 0.0096 | |
| Percentage of shareholdings foreign individuals | CurrentYearInstant_OrdinaryShareMember | 0.0871 | |
| Percentage of shareholdings individuals and others | CurrentYearInstant_OrdinaryShareMember | 0.4380 | |
| Number of shares held | CurrentYearInstant_No1MajorShareholdersMember | 2731000 | |
| Shareholding ratio | CurrentYearInstant_No1MajorShareholdersMember | 0.2790 | |
| Number of shares held | CurrentYearInstant_No2MajorShareholdersMember | 837000 | |
| Shareholding ratio | CurrentYearInstant_No2MajorShareholdersMember | 0.0856 | |
| Number of shares held | CurrentYearInstant_No3MajorShareholdersMember | 489000 | |
| Shareholding ratio | CurrentYearInstant_No3MajorShareholdersMember | 0.0499 | |
| Number of shares held | CurrentYearInstant_No4MajorShareholdersMember | 312000 | |
| Shareholding ratio | CurrentYearInstant_No4MajorShareholdersMember | 0.0319 | |
| Number of shares held | CurrentYearInstant_No5MajorShareholdersMember | 282000 | |
| Shareholding ratio | CurrentYearInstant_No5MajorShareholdersMember | 0.0288 | |
| Number of shares held | CurrentYearInstant_No6MajorShareholdersMember | 247000 | |
| Shareholding ratio | CurrentYearInstant_No6MajorShareholdersMember | 0.0252 | |
| Number of shares held | CurrentYearInstant_No7MajorShareholdersMember | 204000 | |
| Shareholding ratio | CurrentYearInstant_No7MajorShareholdersMember | 0.0208 | |
| Number of shares held | CurrentYearInstant_No8MajorShareholdersMember | 153000 | |
| Shareholding ratio | CurrentYearInstant_No8MajorShareholdersMember | 0.0156 | |
| Number of shares held | CurrentYearInstant_No9MajorShareholdersMember | 120000 | |
| Shareholding ratio | CurrentYearInstant_No9MajorShareholdersMember | 0.0123 | |
| Number of shares held | CurrentYearInstant_No10MajorShareholdersMember | 120000 | |
| Shareholding ratio | CurrentYearInstant_No10MajorShareholdersMember | 0.0122 | |
| Number of shares held | CurrentYearInstant | 5498000 | |
| Shareholding ratio | CurrentYearInstant | 0.5618 | |
| Number of shares issued shares voting rights | CurrentYearInstant_SharesWithNoVotingRightsMember | － | |
| Number of shares issued shares voting rights | CurrentYearInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | CurrentYearInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | CurrentYearInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | CurrentYearInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember | 20200 | |
| Number of voting rights issued shares voting rights | CurrentYearInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 97835 | |
| Number of shares issued shares voting rights | CurrentYearInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 9783500 | |
| Number of shares issued shares voting rights | CurrentYearInstant_OrdinarySharesSharesLessThanOneUnitMember | 3300 | |
| Number of shares issued shares voting rights | CurrentYearInstant | 9807000 | |
| Number of voting rights issued shares voting rights | CurrentYearInstant | 97835 | |
| Number of shares held in own name treasury shares etc | CurrentYearInstant_Row1Member | 20200 | |
| Number of shares held in others names treasury shares etc | CurrentYearInstant_Row1Member | － | |
| Total number of shares held treasury shares etc | CurrentYearInstant_Row1Member | 20200 | |
| Shareholding ratio treasury shares etc | CurrentYearInstant_Row1Member | 0.0020 | |
| Number of shares held in own name treasury shares etc | CurrentYearInstant | 20200 | |
| Number of shares held in others names treasury shares etc | CurrentYearInstant | － | |
| Total number of shares held treasury shares etc | CurrentYearInstant | 20200 | |
| Shareholding ratio treasury shares etc | CurrentYearInstant | 0.0020 | |
| Number of male directors and other officers | FilingDateInstant | 7 | |
| Number of female directors and other officers | FilingDateInstant | 0 | |
| Ratio of female directors and other officers | FilingDateInstant | 0.00 | |
| Number of shares held other than ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E30998-000KyuseHiroyukiMember | 247300 | |
| Number of shares held other than ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E30998-000TanakaKatsunoriMember | 105600 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |